A breakthrough drug that can halve cholesterol levels without the side effects of statins goes on sale tomorrow.
Heralded as a ‘sea change’ in heart treatments, Repatha is the first new cholesterol-busting medication since the 1980s.
The drug – the first alternative treatment for people who suffer unpleasant side effects from statins – reduced levels of ‘bad’ LDL cholesterol by 55 per cent in clinical trials.
It can also be taken alongside statins, and patients who took both for 12 weeks were shown to have cholesterol levels 75 per cent lower than those given statins alone.
Repatha has been approved as a safe and effective treatment by the European Medicines Agency, so when stocks of the drug arrive in Britain tomorrow it can be prescribed by private doctors immediately.
But the drug will not be made available to NHS patients for at least eight months. Heath service rationing body Nice is currently reviewing whether Repatha offers sufficient value for money, with a report due next April.
The drug, which is also known as evolocumab, has a list price of £170 per dose, taken fortnightly via a pre-filled pen injection. Over the course of a year this is more than £4,000 per patient, although the NHS will be offered a discount on the price.
Info from here http://www.dailymail.co.uk/health/article-3216517/An-alternative-statins-New-drug-halves-cholesterol-fewer-effects-goes-sale-UK-tomorrow.html
Pay four grand a year for what? As far as I know lowering LDL has never been proved to prolong life, in fact in older people the lower the LDL the earlier the death. If this drug takes off in the UK, at anywhere near the price discussed, I will eat my hat.
Heralded as a ‘sea change’ in heart treatments, Repatha is the first new cholesterol-busting medication since the 1980s.
The drug – the first alternative treatment for people who suffer unpleasant side effects from statins – reduced levels of ‘bad’ LDL cholesterol by 55 per cent in clinical trials.
It can also be taken alongside statins, and patients who took both for 12 weeks were shown to have cholesterol levels 75 per cent lower than those given statins alone.
Repatha has been approved as a safe and effective treatment by the European Medicines Agency, so when stocks of the drug arrive in Britain tomorrow it can be prescribed by private doctors immediately.
But the drug will not be made available to NHS patients for at least eight months. Heath service rationing body Nice is currently reviewing whether Repatha offers sufficient value for money, with a report due next April.
The drug, which is also known as evolocumab, has a list price of £170 per dose, taken fortnightly via a pre-filled pen injection. Over the course of a year this is more than £4,000 per patient, although the NHS will be offered a discount on the price.
Info from here http://www.dailymail.co.uk/health/article-3216517/An-alternative-statins-New-drug-halves-cholesterol-fewer-effects-goes-sale-UK-tomorrow.html
Pay four grand a year for what? As far as I know lowering LDL has never been proved to prolong life, in fact in older people the lower the LDL the earlier the death. If this drug takes off in the UK, at anywhere near the price discussed, I will eat my hat.